These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 20409772)
41. Estrogen and progesterone receptor status in breast cancer in Kuwait female population. Paszko Z; Omar YT; Nasralla MY; Jazzaf H; Bouzubar N; Temmim L; Padzik H Neoplasma; 1993; 40(2):127-32. PubMed ID: 8350956 [TBL] [Abstract][Full Text] [Related]
42. [Hormone receptors of human breast cancer. I. Determination of estrogen and progesterone receptors in human breast cancer]. Zhang HY Zhonghua Zhong Liu Za Zhi; 1983 May; 5(3):168-71. PubMed ID: 6628170 [No Abstract] [Full Text] [Related]
43. [Hormone receptors and breast cancer prognosis]. Saez S; Pichon MF Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701 [TBL] [Abstract][Full Text] [Related]
44. Menstrual cycle and hormone receptor status in breast cancer patients. Atalay C; Kanliöz M; Altinok M Neoplasma; 2002; 49(4):278. PubMed ID: 12382029 [TBL] [Abstract][Full Text] [Related]
45. [Tamoxifen-induced progesterone receptors in breast tumors]. Tsyrlina EV; Semiglazov VF; Nurgaziev KSh; Ivanova OA Vopr Onkol; 1991; 37(9-10):916-21. PubMed ID: 1842650 [TBL] [Abstract][Full Text] [Related]
46. Screening and detection of breast cancer and prostate cancer. Saloustros E; Mavroudis D JAMA; 2010 Mar; 303(11):1032; author reply 1033-4. PubMed ID: 20233817 [No Abstract] [Full Text] [Related]
47. The emerging epidemic of estrogen-related cancers in young women in a developing Asian country. Lin CH; Chen YC; Chiang CJ; Lu YS; Kuo KT; Huang CS; Cheng WF; Lai MS; You SL; Cheng AL Int J Cancer; 2012 Jun; 130(11):2629-37. PubMed ID: 21702035 [TBL] [Abstract][Full Text] [Related]
48. Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries. Daubisse-Marliac L; Delafosse P; Boitard JB; Poncet F; Grosclaude P; Colonna M Ann Oncol; 2011 Feb; 22(2):329-34. PubMed ID: 20682549 [TBL] [Abstract][Full Text] [Related]
49. [Hormone replacement therapy in France 5 years after the decrease in use]. Gompel A Rev Prat; 2010 Oct; 60(8):1118-21. PubMed ID: 21197747 [TBL] [Abstract][Full Text] [Related]
50. Seasonal trends in the self-detection of breast cancer: indications from the Cancer and Steroid Hormone (CASH) study. Ross JA; Severson RK; Davis S; Stanford JL; Potter JD Breast Cancer Res Treat; 1997 Jan; 42(2):187-92. PubMed ID: 9138608 [TBL] [Abstract][Full Text] [Related]
51. Changing pattern of breast cancer. Is it a reflection of changing etiology? Swanson GM Cancer; 1994 Sep; 74(5):1523-4. PubMed ID: 8062185 [No Abstract] [Full Text] [Related]
52. Encouraging trends in breast cancer incidence. Mettlin C Cancer; 1993 Aug; 72(3):637-8. PubMed ID: 8334618 [No Abstract] [Full Text] [Related]
53. Letter: Incidence of breast cancer. Blumenson LE JAMA; 1976 Jul; 236(3):251. PubMed ID: 947020 [No Abstract] [Full Text] [Related]
54. Clarification Regarding Breast Cancer Stage in France. Molinié F; Lafay L; Rogel A JAMA Oncol; 2024 Jun; 10(6):831-832. PubMed ID: 38662355 [No Abstract] [Full Text] [Related]
55. Temporal trends in breast cancer incidence. MacMahon B Am J Epidemiol; 1982 Nov; 116(5):867. PubMed ID: 7148809 [No Abstract] [Full Text] [Related]
56. [Tracing cancer of the breast before 40 years of age]. Guerin RA Presse Med; 1989 May; 18(19):988. PubMed ID: 2525734 [No Abstract] [Full Text] [Related]
57. [Erratum to: "The frequency of cancer in France: Most recent data and trends" [Bull. Cancer 104 (2017) 20-29]]. Ribassin-Majed L; Le Teuff G; Hill C Bull Cancer; 2017 Apr; 104(4):388. PubMed ID: 28302268 [No Abstract] [Full Text] [Related]
58. The Malaysian Breast Cancer Survivorship Cohort (MyBCC): a study protocol. Islam T; Bhoo-Pathy N; Su TT; Majid HA; Nahar AM; Ng CG; Dahlui M; Hussain S; Cantwell M; Murray L; Taib NA; BMJ Open; 2015 Oct; 5(10):e008643. PubMed ID: 26503386 [TBL] [Abstract][Full Text] [Related]
59. Spectrum of very early breast cancer in a setting without organised screening. Bhoo-Pathy N; Subramaniam S; Taib NA; Hartman M; Alias Z; Tan GH; Ibrahim RI; Yip CH; Verkooijen HM Br J Cancer; 2014 Apr; 110(9):2187-94. PubMed ID: 24736587 [TBL] [Abstract][Full Text] [Related]
60. Detection of prognostic factors in metastatic breast cancer. Tazhibi M; Fayaz M; Mokarian F J Res Med Sci; 2013 Apr; 18(4):283-90. PubMed ID: 24124424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]